| Adjuvant imatinib mesylate after resection of localised, primary gastrointestinal stromal tumour: a randomised, double-blind, placebo-controlled trial RP DeMatteo, KV Ballman, CR Antonescu, RG Maki, PWT Pisters, ... The lancet 373 (9669), 1097-1104, 2009 | 1704 | 2009 |
| Soft tissue sarcoma, version 2.2018, NCCN clinical practice guidelines in oncology M Von Mehren, RL Randall, RS Benjamin, S Boles, MM Bui, KN Ganjoo, ... Journal of the National Comprehensive Cancer Network 16 (5), 536-563, 2018 | 603 | 2018 |
| Effects of limited work hours on surgical training CB Barden, MC Specht, MD McCarter, JM Daly, TJ Fahey III Journal of the American College of Surgeons 195 (4), 531-538, 2002 | 387 | 2002 |
| Pathologic and molecular features correlate with long-term outcome after adjuvant therapy of resected primary GI stromal tumor: the ACOSOG Z9001 trial CL Corless, KV Ballman, CR Antonescu, V Kolesnikova, RG Maki, ... Journal of Clinical Oncology 32 (15), 1563, 2014 | 348 | 2014 |
| Soft tissue sarcoma, version 2.2016, NCCN clinical practice guidelines in oncology M Von Mehren, RL Randall, RS Benjamin, S Boles, MM Bui, EU Conrad, ... Journal of the National Comprehensive Cancer Network 14 (6), 758-786, 2016 | 314 | 2016 |
| Neoadjuvant FOLFIRINOX in patients with borderline resectable pancreatic cancer: a systematic review and patient-level meta-analysis QP Janssen, S Buettner, M Suker, BR Beumer, P Addeo, P Bachellier, ... JNCI: Journal of the National Cancer Institute 111 (8), 782-794, 2019 | 289 | 2019 |
| ALDH1A isozymes are markers of human melanoma stem cells and potential therapeutic targets Y Luo, K Dallaglio, Y Chen, WA Robinson, SE Robinson, MD McCarter, ... Stem cells 30 (10), 2100-2113, 2012 | 287 | 2012 |
| CTL fail to accumulate at sites of HIV-1 replication in lymphoid tissue E Connick, T Mattila, JM Folkvord, R Schlichtemeier, AL Meditz, MG Ray, ... The Journal of Immunology 178 (11), 6975-6983, 2007 | 256 | 2007 |
| Post-discharge venous thromboembolism after cancer surgery: extending the case for extended prophylaxis RP Merkow, KY Bilimoria, MD McCarter, ME Cohen, CC Barnett, ... Annals of surgery 254 (1), 131-137, 2011 | 239 | 2011 |
| Effect of body mass index on short-term outcomes after colectomy for cancer RP Merkow, KY Bilimoria, MD McCarter, DJ Bentrem Journal of the American College of Surgeons 208 (1), 53-61, 2009 | 236 | 2009 |
| Interim analysis of a prospective phase I/II trial of SBRT for liver metastases BD Kavanagh, TE Schefter, HR Cardenes, VW Stieber, D Raben, ... Acta oncologica 45 (7), 848-855, 2006 | 233 | 2006 |
| NCCN guidelines insights: soft tissue sarcoma, version 1.2021: featured updates to the NCCN guidelines M von Mehren, JM Kane, MM Bui, E Choy, M Connelly, S Dry, KN Ganjoo, ... Journal of the National Comprehensive Cancer Network 18 (12), 1604-1612, 2020 | 224 | 2020 |
| Antigen-Presenting Intratumoral B Cells Affect CD4+ TIL Phenotypes in Non–Small Cell Lung Cancer Patients TC Bruno, PJ Ebner, BL Moore, OG Squalls, KA Waugh, EB Eruslanov, ... Cancer immunology research 5 (10), 898-907, 2017 | 212 | 2017 |
| Virtual memory T cells develop and mediate bystander protective immunity in an IL-15-dependent manner JT White, EW Cross, MA Burchill, T Danhorn, MD McCarter, HR Rosen, ... Nature communications 7 (1), 1-13, 2016 | 200 | 2016 |
| Gut dendritic cell activation links an altered colonic microbiome to mucosal and systemic T-cell activation in untreated HIV-1 infection SM Dillon, EJ Lee, CV Kotter, GL Austin, S Gianella, B Siewe, DM Smith, ... Mucosal immunology 9 (1), 24-37, 2016 | 200 | 2016 |
| Microscopically positive margins for primary gastrointestinal stromal tumors: analysis of risk factors and tumor recurrence MD McCarter, CR Antonescu, KV Ballman, RG Maki, PWT Pisters, ... Journal of the American College of Surgeons 215 (1), 53-59, 2012 | 195 | 2012 |
| Prognostic impact of micrometastases in colon cancer: interim results of a prospective multicenter trial AJ Bilchik, DSB Hoon, S Saha, RR Turner, D Wiese, M DiNome, ... Annals of surgery 246 (4), 568-577, 2007 | 182 | 2007 |
| Long-term results of adjuvant imatinib mesylate in localized, high-risk, primary gastrointestinal stromal tumor: ACOSOG Z9000 (Alliance) intergroup phase 2 trial RP DeMatteo, KV Ballman, CR Antonescu, C Corless, V Kolesnikova, ... Annals of surgery 258 (3), 422-429, 2013 | 181 | 2013 |
| Characteristics of 10-year survivors of pancreatic ductal adenocarcinoma A Paniccia, P Hosokawa, W Henderson, RD Schulick, BH Edil, ... JAMA surgery 150 (8), 701-710, 2015 | 177 | 2015 |
| Comparing short-term and oncologic outcomes of minimally invasive versus open pancreaticoduodenectomy across low and high volume centers RJ Torphy, C Friedman, A Halpern, BC Chapman, SS Ahrendt, ... Annals of surgery 270 (6), 1147-1155, 2019 | 171 | 2019 |
